Paracoccidioides-host Interaction: An Overview on Recent Advances in the Paracoccidioidomycosis

HC De Oliveira, PA Assato, CM Marcos… - Frontiers in …, 2015 - frontiersin.org
Paracoccidioides brasiliensis and P. lutzii are etiologic agents of paracoccidioidomycosis
(PCM), an important endemic mycosis in Latin America. During its evolution, these fungi …

Advances and challenges in paracoccidioidomycosis serology caused by Paracoccidioides species complex: an update

JF da Silva, HC de Oliveira, CM Marcos… - … and infectious disease, 2016 - Elsevier
Understanding the possible methodologies for the rapid and inexpensive identification of
fungal infections is essential for disease diagnosis, but there are some limitations. To help …

Mesoporous SBA-16 silica nanoparticles as a potential vaccine adjuvant against Paracoccidioides brasiliensis

DCF Soares, LM Soares, AM de Goes, EM Melo… - Microporous and …, 2020 - Elsevier
Nanostructured materials including mesoporous silica nanoparticles (MSNs) have attracted
attention due to their recently discovered capability to increase the immune responses …

Inhibition of PbGP43 Expression May Suggest that gp43 is a Virulence Factor in Paracoccidioides brasiliensis

I Torres, O Hernandez, D Tamayo, JF Munoz… - PloS one, 2013 - journals.plos.org
Glycoprotein gp43 is an immunodominant diagnostic antigen for paracoccidioidomycosis
caused by Paracoccidioides brasiliensis. It is abundantly secreted in isolates such as …

Therapeutic Administration of Recombinant Paracoccin Confers Protection against Paracoccidioides brasiliensis Infection: Involvement of TLRs

ACP Alegre-Maller, FC Mendonça… - PLoS neglected …, 2014 - journals.plos.org
Background Paracoccin (PCN) is an N-acetylglucosamine-binding lectin from the human
pathogenic fungus Paracoccidioides brasiliensis. Recombinant PCN (rPCN) induces a T …

Therapeutic DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis

GMG Rittner, JE Munoz, AF Marques… - PLoS neglected …, 2012 - journals.plos.org
Paracoccidioidomycosis (PCM), caused by Paracoccidioides brasiliensis, is the most
prevalent invasive fungal disease in South America. Systemic mycoses are the 10th most …

Current strategies for diagnosis of paracoccidioidomycosis and prospects of methods based on gold nanoparticles

C Silva Ferreira, EM de Castro Ribeiro… - Future …, 2016 - Taylor & Francis
Paracoccidioidomycosis (PCM) is a human systemic granulomatous mycosis caused by
thermodimorphic fungi from Paracoccidioides genus. The disease is prevalent in Latin …

Combined use of Paracoccidioides brasiliensis recombinant rPb27 and rPb40 antigens in an enzyme-linked immunosorbent assay for immunodiagnosis of …

VC Fernandes, JB Coitinho, JMR Veloso… - Journal of …, 2011 - Elsevier
Paracoccidioidomycosis (PCM) is one of the most important endemic mycoses in Latin
America; it's usually diagnosed by observation and/or isolation of the etiologic agent …

Nanoformulated CHO-rPb27 vaccine enhances immunity and controls infection, mitigating lung inflammation and dysfunction during experimental …

EA Morais, EM do Nascimento Martins… - International Journal of …, 2024 - Elsevier
Paracoccidioidomycosis (PCM) is a systemic mycosis caused by the dimorphic fungus within
the genus Paracoccidioides, particularly Paracoccidioides brasiliensis. The traditional …

New advances in the development of a vaccine against paracoccidioidomycosis

LR Travassos, CP Taborda - Frontiers in Microbiology, 2012 - frontiersin.org
Paracoccidioidomycosis (PCM) is an endemic Latin American mycosis caused by
Paracoccidioides brasiliensis and also by the recently described P. lutzii. The systemic …